Maine

AMM-ADAntidepressant Medication Management: Age 18 and Older

Percentage with a Diagnosis of Major Depression who were Treated with and Remained on an Antidepressant Medication for 12 Weeks: Ages 18 to 64

AMM-ADAntidepressant Medication Management: Age 18 and Older

Percentage with a Diagnosis of Major Depression who were Treated with and Remained on an Antidepressant Medication for the Continuation Phase (6 Months): Ages 18 to 64

FUA-ADFollow-Up After Emergency Department Visit for Substance Use: Age 18 and Older

Percentage of Emergency Department (ED) Visits for Substance Use Disorder (SUD) or Drug Overdose with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64

FUA-ADFollow-Up After Emergency Department Visit for Substance Use: Age 18 and Older

Percentage of Emergency Department (ED) Visits for Substance Use Disorder (SUD) or Drug Overdose with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64

FUH-ADFollow-Up After Hospitalization for Mental Illness: Age 18 and Older

Percentage of Discharges for Adults Hospitalized for Treatment of Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64

FUH-ADFollow-Up After Hospitalization for Mental Illness: Age 18 and Older

Percentage of Discharges for Adults Hospitalized for Treatment of Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64

FUM-ADFollow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older

Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64

FUM-ADFollow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older

Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64

IET-ADInitiation and Engagement of Substance Use Disorder Treatment: Age 18 and Older

Percentage of New Episodes of Opioid Use Disorder with Initiation of SUD Treatment within 14 Days: Ages 18 to 64

IET-ADInitiation and Engagement of Substance Use Disorder Treatment: Age 18 and Older

Percentage of New Episodes of Opioid Use Disorder with Engagement of SUD Treatment within 34 Days of Initiation: Ages 18 to 64

IET-ADInitiation and Engagement of Substance Use Disorder Treatment: Age 18 and Older

Percentage of New Episodes of Alcohol Use Disorder with Engagement of SUD Treatment within 34 Days of Initiation: Ages 18 to 64

IET-ADInitiation and Engagement of Substance Use Disorder Treatment: Age 18 and Older

Percentage of New Episodes of Total SUD with Engagement of SUD Treatment within 34 Days of Initiation: Ages 18 to 64

IET-ADInitiation and Engagement of Substance Use Disorder Treatment: Age 18 and Older

Percentage of New Episodes of Other SUD with Engagement of SUD Treatment within 34 Days of Initiation: Ages 18 to 64

IET-ADInitiation and Engagement of Substance Use Disorder Treatment: Age 18 and Older

Percentage of New Episodes of Other SUD with Initiation of SUD Treatment within 14 Days: Ages 18 to 64

IET-ADInitiation and Engagement of Substance Use Disorder Treatment: Age 18 and Older

Percentage of New Episodes of Alcohol Use Disorder with Initiation of SUD Treatment within 14 Days: Ages 18 to 64

IET-ADInitiation and Engagement of Substance Use Disorder Treatment: Age 18 and Older

Percentage of New Episodes of Total SUD with Initiation of SUD Treatment within 14 Days: Ages 18 to 64

OUD-ADUse of Pharmacotherapy for Opioid Use Disorder: Ages 18 to 64

Percentage with an Opioid Use Disorder who Filled a Prescription for or were Administered or Dispensed Methadone: Ages 18 to 64

OUD-ADUse of Pharmacotherapy for Opioid Use Disorder: Ages 18 to 64

Percentage with an Opioid Use Disorder who Filled a Prescription for or were Administered or Dispensed an FDA-Approved Medication for the Disorder: Total Rate: Ages 18 to 64

OUD-ADUse of Pharmacotherapy for Opioid Use Disorder: Ages 18 to 64

Percentage with an Opioid Use Disorder who Filled a Prescription for or were Administered or Dispensed Buprenorphine: Ages 18 to 64

OUD-ADUse of Pharmacotherapy for Opioid Use Disorder: Ages 18 to 64

Percentage with an Opioid Use Disorder who Filled a Prescription for or were Administered or Dispensed Long-acting Injectable Naltrexone: Ages 18 to 64

OUD-ADUse of Pharmacotherapy for Opioid Use Disorder: Ages 18 to 64

Percentage with an Opioid Use Disorder who Filled a Prescription for or were Administered or Dispensed Oral Naltrexone: Ages 18 to 64

SAA-ADAdherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and Older

Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and Older

SSD-ADDiabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64

Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64

ADD-CHFollow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication: Ages 6 to 12

Percentage Newly Prescribed ADHD Medication with at Least One Follow-Up Visit During the 30-Day Initiation Phase: Ages 6 to 12

ADD-CHFollow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication: Ages 6 to 12

Percentage Newly Prescribed ADHD Medication with at Least Two Follow-Up Visits in the 9-Month Continuation and Maintenance Phase: Ages 6 to 12

APM-CHMetabolic Monitoring for Children and Adolescents on Antipsychotics: Ages 1 to 17

Percentage with Two or More Antipsychotic Prescriptions that had Metabolic Testing for Blood Glucose and Cholesterol: Ages 1 to 17

APM-CHMetabolic Monitoring for Children and Adolescents on Antipsychotics: Ages 1 to 17

Percentage with Two or More Antipsychotic Prescriptions that had Metabolic Testing for Blood Glucose and Cholesterol: Ages 1 to 11

APM-CHMetabolic Monitoring for Children and Adolescents on Antipsychotics: Ages 1 to 17

Percentage with Two or More Antipsychotic Prescriptions that had Metabolic Testing for Blood Glucose: Ages 12 to 17

APM-CHMetabolic Monitoring for Children and Adolescents on Antipsychotics: Ages 1 to 17

Percentage with Two or More Antipsychotic Prescriptions that had Metabolic Testing for Blood Glucose: Ages 1 to 11

APM-CHMetabolic Monitoring for Children and Adolescents on Antipsychotics: Ages 1 to 17

Percentage with Two or More Antipsychotic Prescriptions that had Metabolic Testing for Cholesterol: Ages 12 to 17

APM-CHMetabolic Monitoring for Children and Adolescents on Antipsychotics: Ages 1 to 17

Percentage with Two or More Antipsychotic Prescriptions that had Metabolic Testing for Cholesterol: Ages 1 to 11

APM-CHMetabolic Monitoring for Children and Adolescents on Antipsychotics: Ages 1 to 17

Percentage with Two or More Antipsychotic Prescriptions that had Metabolic Testing for Blood Glucose and Cholesterol: Ages 12 to 17

APM-CHMetabolic Monitoring for Children and Adolescents on Antipsychotics: Ages 1 to 17

Percentage with Two or More Antipsychotic Prescriptions that had Metabolic Testing for Cholesterol: Ages 1 to 17

APM-CHMetabolic Monitoring for Children and Adolescents on Antipsychotics: Ages 1 to 17

Percentage with Two or More Antipsychotic Prescriptions that had Metabolic Testing for Blood Glucose: Ages 1 to 17

APP-CHUse of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics: Ages 1 to 17

Percentage who had a New Prescription for an Antipsychotic Medication and had Documentation of Psychosocial Care as First-Line Treatment: Ages 1 to 17

APP-CHUse of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics: Ages 1 to 17

Percentage who had a New Prescription for an Antipsychotic Medication and had Documentation of Psychosocial Care as First-Line Treatment: Ages 1 to 11

APP-CHUse of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics: Ages 1 to 17

Percentage who had a New Prescription for an Antipsychotic Medication and had Documentation of Psychosocial Care as First-Line Treatment: Ages 12 to 17

FUA-CHFollow-Up After Emergency Department Visit for Substance Use: Ages 13 to 17

Percentage of Emergency Department (ED) Visits for Substance Use Disorder (SUD) or Drug Overdose with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 13 to 17

FUA-CHFollow-Up After Emergency Department Visit for Substance Use: Ages 13 to 17

Percentage of Emergency Department (ED) Visits for Substance Use Disorder (SUD) or Drug Overdose with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 13 to 17

FUH-CHFollow-Up After Hospitalization for Mental Illness: Ages 6 to 17

Percentage of Discharges for Children Hospitalized for Treatment of Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 6 to 17

FUH-CHFollow-Up After Hospitalization for Mental Illness: Ages 6 to 17

Percentage of Discharges for Children Hospitalized for Treatment of Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 6 to 17

FUM-CHFollow-Up After Emergency Department Visit for Mental Illness: Ages 6 to 17

Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 6 to 17

FUM-CHFollow-Up After Emergency Department Visit for Mental Illness: Ages 6 to 17

Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 6 to 17

AAB-ADAvoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis: Age 18 and Older

Percentage of Episodes for Beneficiaries with a Diagnosis of Acute Bronchitis/Bronchiolitis that did not Result in an Antibiotic Dispensing Event: Ages 18 to 64

AMR-ADAsthma Medication Ratio: Ages 19 to 64

Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64

AMR-ADAsthma Medication Ratio: Ages 19 to 64

Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50

AMR-ADAsthma Medication Ratio: Ages 19 to 64

Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64

COB-ADConcurrent Use of Opioids and Benzodiazepines: Age 18 and Older

Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines for 30 or More Cumulative Days: Ages 18 to 64

OHD-ADUse of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older

Percentage of Adults Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents (MME) for a Period of 90 Days or More: Ages 18 to 64

PCR-ADPlan All-Cause Readmissions: Ages 18 to 64

Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64

PQI01-ADPQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older

Hospitalizations for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64

PQI05-ADPQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older

Hospitalizations for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64

PQI08-ADPQI 08: Heart Failure Admission Rate: Age 18 and Older

Hospitalizations for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64

PQI15-ADPQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39

Hospitalizations for Asthma per 100,000 Beneficiary Months: Ages 18 to 39

AAB-CHAvoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis: Ages 3 Months to 17 Years

Percentage of Episodes for Beneficiaries with a Diagnosis of Acute Bronchitis/Bronchiolitis that did not Result in an Antibiotic Dispensing Event: Ages 3 Months to 17 Years

AMB-CHAmbulatory Care: Emergency Department (ED) Visits: Ages 0 to 19

Emergency Department Visits per 1,000 Beneficiary Months: Ages 0 to 19

AMR-CHAsthma Medication Ratio: Ages 5 to 18

Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 5 to 18

AMR-CHAsthma Medication Ratio: Ages 5 to 18

Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 12 to 18

AMR-CHAsthma Medication Ratio: Ages 5 to 18

Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 5 to 11

OEV-CHOral Evaluation, Dental Services: Ages <1 through 20

Percentage of Enrolled Children Under Age 21 Who Received a Comprehensive or Periodic Oral Evaluation: Ages <1 through 20

SFM-CHSealant Receipt on Permanent First Molars: Age 10

Percentage who Received a Sealant on at Least One Permanent First Molar Tooth by their 10th Birthday

SFM-CHSealant Receipt on Permanent First Molars: Age 10

Percentage who Received Sealants on All Four Permanent First Molars by their 10th Birthday

TFL-CHTopical Fluoride for Children: Ages 1 through 20

Percentage of Enrolled Children who Received at Least Two Topical Fluoride Applications as Dental or Oral Health Services: Total (Ages 1 through 20)

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Rated Their Health Care a "9" or "10" on a Scale from 0 to 10, with 10 Representing the Highest Score: General Child (GC) Population Ages 0 to 17

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Selected They "Always" Got Needed Care, on a Four-Point Scale Ranging from "Never" to "Always": Children with Chronic Conditions (CCC) Population Ages 0 to 17

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Selected They "Always" Got Needed Care, on a Four-Point Scale Ranging from "Never" to "Always": General Child (GC) Population Ages 0 to 17

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Rated Their Health Care a "9" or "10" on a Scale from 0 to 10, with 10 Representing the Highest Score: Children with Chronic Conditions (CCC) Population Ages 0 to 17

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Selected They "Always" Got Care Quickly, on a Four-Point Scale Ranging from "Never" to "Always": General Child (GC) Population Ages 0 to 17

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Rated Their Health Plan a "9" or "10" on a Scale from 0 to 10, with 10 Representing the Highest Score: Children with Chronic Conditions (CCC) Population Ages 0 to 17

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Rated Their Specialist a "9" or "10" on a Scale from 0 to 10, with 10 Representing the Highest Score: General Child (GC) Population Ages 0 to 17

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Rated Their Health Plan a "9" or "10" on a Scale from 0 to 10, with 10 Representing the Highest Score: General Child (GC) Population Ages 0 to 17

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Rated Their Specialist a "9" or "10" on a Scale from 0 to 10, with 10 Representing the Highest Score: Children with Chronic Conditions (CCC) Population Ages 0 to 17

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Selected that Their Doctor Communicates Well "Always," on a Four-Point Scale Ranging from "Never" to "Always": Children with Chronic Conditions (CCC) Population Ages 0 to 17

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Selected They "Always" Got Care Quickly, on a Four-Point Scale Ranging from "Never" to "Always": Children with Chronic Conditions (CCC) Population Ages 0 to 17

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Rated Their Personal Doctor a "9" or "10" on a Scale from 0 to 10, with 10 Representing the Highest Score: Children with Chronic Conditions (CCC) Population Ages 0 to 17

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Selected that Their Doctor Communicates Well "Always," on a Four-Point Scale Ranging from "Never" to "Always": General Child (GC) Population Ages 0 to 17

CPC-CHCAHPS Health Plan Survey 5.1H - Child Version Including Medicaid and Children with Chronic Conditions Supplemental Items: Ages 0 to 17

Percentage whose Caregiver Rated Their Personal Doctor a "9" or "10" on a Scale from 0 to 10, with 10 Representing the Highest Score: General Child (GC) Population Ages 0 to 17

CCW-ADContraceptive Care - All Women Ages 21 to 44

Percentage of All Women at Risk of Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44

CCW-ADContraceptive Care - All Women Ages 21 to 44

Percentage of All Women at Risk of Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44

CCW-CHContraceptive Care - All Women Ages 15 to 20

Percentage of All Women at Risk of Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 15 to 20

CCW-CHContraceptive Care - All Women Ages 15 to 20

Percentage of All Women at Risk of Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 15 to 20

LBW-CHLive Births Weighing Less Than 2,500 Grams

Percentage of Live Births Weighing Less Than 2,500 Grams

LRCD-CHLow-Risk Cesarean Delivery

Percentage of Nulliparous, Term, Singleton, in a Cephalic Presentation Births Delivered by Cesarean

PPC2-CHPrenatal and Postpartum Care: Under Age 21

Percentage of Women Under Age 21 Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery

PPC2-CHPrenatal and Postpartum Care: Under Age 21

Percentage of Women Under Age 21 Delivering a Live Birth with a Prenatal Care Visit in the First Trimester, on or before the Enrollment Start Date, or within 42 Days of Enrollment in Medicaid or CHIP

BCS-ADBreast Cancer Screening: Ages 50 to 74

Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64

CCS-ADCervical Cancer Screening: Ages 21 to 64

Percentage of Women Screened for Cervical Cancer: Ages 21 to 64

CHL-ADChlamydia Screening in Women Ages 21 to 24

Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24

COL-ADColorectal Cancer Screening: Ages 45 to 75

Percentage who had Appropriate Screening for Colorectal Cancer: Ages 46 to 50

COL-ADColorectal Cancer Screening: Ages 45 to 75

Percentage who had Appropriate Screening for Colorectal Cancer: Ages 51 to 65

CHL-CHChlamydia Screening in Women Ages 16 to 20

Percentage of Sexually Active Women Screened for Chlamydia: Ages 16 to 20

DEV-CHDevelopmental Screening in the First Three Years of Life: Ages 0 to 3

Percentage Screened for Risk of Developmental, Behavioral, and Social Delays Using a Standardized Screening Tool: Ages 0 to 3

LSC-CHLead Screening in Children: Age 2

Percentage who had One or More Capillary or Venous Lead Blood Test for Lead Poisoning by their Second Birthday

W30-CHWell-Child Visits in the First 30 Months of Life

Percentage of Children who had 2 or More Well-Child Visits with a Primary Care Practitioner during the 15th to 30th Months of Life

W30-CHWell-Child Visits in the First 30 Months of Life

Percentage of Children who had 6 or More Well-Child Visits with a Primary Care Practitioner during the First 15 Months of Life

WCC-CHWeight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents: Ages 3 to 17

Percentage with an Outpatient Visit and Body Mass Index Percentile Documented in the Medical Record: Ages 3 to 17

WCC-CHWeight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents: Ages 3 to 17

Percentage with an Outpatient Visit and Counseling for Physical Activity Documented in the Medical Record: Ages 3 to 17

WCC-CHWeight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents: Ages 3 to 17

Percentage with an Outpatient Visit and Counseling for Nutrition Documented in the Medical Record: Ages 3 to 17

WCV-CHChild and Adolescent Well-Care Visits: Ages 3 to 21

Percentage with at Least 1 Well-Care Visit with a Primary Care Practitioner or Obstetrician/Gynecologist: Ages 18 to 21

WCV-CHChild and Adolescent Well-Care Visits: Ages 3 to 21

Percentage with at Least 1 Well-Care Visit with a Primary Care Practitioner or Obstetrician/Gynecologist: Ages 3 to 11

WCV-CHChild and Adolescent Well-Care Visits: Ages 3 to 21

Percentage with at Least 1 Well-Care Visit with a Primary Care Practitioner or Obstetrician/Gynecologist: Ages 12 to 17

WCV-CHChild and Adolescent Well-Care Visits: Ages 3 to 21

Percentage with at Least 1 Well-Care Visit with a Primary Care Practitioner or Obstetrician/Gynecologist: Ages 3 to 21